Publications by authors named "Gerald Aichinger"

Claim this Profile
S
Superior in vitro stimulation of human CD8+ T-cells by whole virus versus split virus influenza vaccines.
Benedict R Halbroth, Alexander Heil, Eva Distler, Martin Dass, Eva M Wagner, Gerald Aichinger

PLoS One· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An inactivated Ross River virus vaccine is well tolerated and immunogenic in an adult population in a randomized phase 3 trial.
Nina Wressnigg, Maikel V W van der Velden, Daniel Portsmouth, Wolfgang Draxler, Maria O'Rourke, Gerald Aichinger

Clin Vaccine Immunol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II randomized double-blind study of the safety and immunogenicity of a nonadjuvanted vero cell culture-derived whole-virus H9N2 influenza vaccine in healthy adults.
Gerald Aichinger, Barbara Grohmann-Izay, Maikel V W van der Velden, Sandor Fritsch, Manuela Koska

Clin Vaccine Immunol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel multivalent OspA vaccine against Lyme borreliosis is safe and immunogenic in an adult population previously infected with Borrelia burgdorferi sensu lato.
Nina Wressnigg, P Noel Barrett, Eva-Maria Pöllabauer, Maria O'Rourke, Daniel Portsmouth, Gerald Aichinger

Clin Vaccine Immunol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuraminidase-Inhibiting Antibody Response to H5N1 Virus Vaccination in Chronically Ill and Immunocompromised Patients.
Richard Fritz, Nicole Hetzelt, Reinhard Ilk, Christine Hohenadl, Maikel V W van der Velden, Gerald Aichinger

Open Forum Infect Dis· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patients.
Maikel V W van der Velden, Alexander Geisberger, Thomas Dvorak, Daniel Portsmouth, Richard Fritz, Gerald Aichinger

Clin Vaccine Immunol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a vero cell culture-derived whole-virus influenza A(H5N1) vaccine in a pediatric population.
Maikel V W van der Velden, Richard Fritz, Eva Maria Pöllabauer, Daniel Portsmouth, M Keith Howard, Gerald Aichinger

J Infect Dis· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lyme disease vaccination: safety first - authors' reply.
P Noel Barrett, Brian A Crowe, Nina Wressnigg, Daniel Portsmouth, Gerald Aichinger

Lancet Infect Dis· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a novel multivalent OspA vaccine against Lyme borreliosis in healthy adults: a double-blind, randomised, dose-escalation phase 1/2 trial.
Nina Wressnigg, Eva-Maria Pöllabauer, Gerald Aichinger, Daniel Portsmouth, Alexandra Löw-Baselli

Lancet Infect Dis· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose priming.
Maikel V W van der Velden, Gerald Aichinger, Eva Maria Pöllabauer, Alexandra Löw-Baselli, Sandor Fritsch

Vaccine· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical development of a Vero cell culture-derived seasonal influenza vaccine.
Hartmut J Ehrlich, Gregory Berezuk, Sandor Fritsch, Gerald Aichinger, Julia Singer

Vaccine· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
Hartmut J Ehrlich, Markus Müller, Herwig Kollaritsch, Fritz Pinl, Bernhard Schmitt, Gerald Aichinger

Vaccine· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individuals.
Hartmut J Ehrlich, Julia Singer, Gregory Berezuk, Sandor Fritsch, Gerald Aichinger

Clin Infect Dis· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine.
Paul A Tambyah, Annelies Wilder-Smith, Borislava G Pavlova, P Noel Barrett, Helen M L Oh, Gerald Aichinger

Vaccine· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trial.
Gerald Aichinger, Hartmut J Ehrlich, John G Aaskov, Sandor Fritsch, Christiane Thomasser

Vaccine· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection.
Georg W Holzer, Sogue Coulibaly, Gerald Aichinger, Helga Savidis-Dacho, Josef Mayrhofer

Vaccine· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial.
P Noel Barrett, Gregory Berezuk, Sandor Fritsch, Gerald Aichinger, Mary Kate Hart

Lancet· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans.
Brian A Crowe, Peter Brühl, Marijan Gerencer, Michael G Schwendinger, Andreas Pilz, Gerald Aichinger

Vaccine· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunodominant T-cell epitopes of hnRNP-A2 associated with disease activity in patients with rheumatoid arthritis.
Sylvie Trembleau, Markus Hoffmann, Brigitte Meyer, Valerie Nell, Helga Radner, Gerald Aichinger

Eur J Immunol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of the human cytomegalovirus pp65-directed T-cell response in healthy HLA-A2-positive individuals.
Juliane Schalich, Oresta Vytvytska, Wolfgang Zauner, Michael B Fischer, Michael Buschle, Gerald Aichinger

Biol Chem· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis